Submit Manuscript    >>    Login | Register

Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation


         Atrial fibrillation (AF) is the most common arrhythmia encountered in the U.S. and the growing burden of AF has profound health implications due to the association of AF with an increased risk of stroke, heart failure, and mortality. AF is a significant risk factor for thromboembolic stroke; and also independently increases total mortality in patients with and without cardiovascular disease.  Various risk stratification schemes such as CHADS2 and CHA2DS2-VASc have been implemented in clinical practice to determine the risk of cardio-embolic stroke, and need for thrombo-prophylaxis in patients with AF. AF is also closely related to the pathophysiology of other cardiovascular and peripheral vascular disease. Many patients with AF have associated atherosclerosis given that many risk factors for atherosclerosis also predispose to AF. Myocardial infarction (MI) is also closely related to AF and its clinical course is affected by new onset AF. This review elucidates the impact of AF on major adverse cardiovascular events and mortality outcomes in relation to stroke, coronary artery disease and peripheral vascular disease.

Credits: Abhishek Maan, MD; Amir Y. Shaikh, MD; Moussa Mansour, MD; Jeremy N. Ruskin, MD; E. Kevin Heist, MD, PhD



Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists